Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02982746
Other study ID # University of Gothenburgh
Secondary ID
Status Completed
Phase N/A
First received December 1, 2016
Last updated December 19, 2016
Start date April 2012
Est. completion date April 2014

Study information

Verified date December 2016
Source Göteborg University
Contact n/a
Is FDA regulated No
Health authority Sweden: Central Ethical Review Board
Study type Interventional

Clinical Trial Summary

At all of the follow-ups, including the worst period (between four and ten weeks), the intervention group reported higher scores than the control group, suggesting in this RCT that adopting the person-centred-care concept was a promising way to improve function and wellbeing in patients with HNC.


Description:

Background: The incidence of head and neck cancer (HNC) is increasing slightly. HNC and its treatment may affect general domains of health-related quality of life (HRQoL) and provoke a variety of adverse symptoms and side effects, both during and after treatment. The objective of this study was to compare a person-centred care intervention in terms of HRQoL, disease-specific symptoms or problems, with traditional care as a control group for patients with HNC. Methods: The intervention and control groups comprised 54 and 42 patients, respectively. Outcome measures used were: the EORTC QLQ-C30 and the EORTC QLQ-C35. Both groups answered the questionnaires at baseline and after 4, 10, 18 and 52 weeks from start of treatment. The questionnaires' scores were compared between groups by using independent samples test (Student's t-test) and non-parametric test (Mann-Whitney U Test) for continuous variables. For categorical data, Fisher's exact test was used. Longitudinal data were analysed using repeated measures in covariance pattern models. Results: At baseline, the intervention and control groups were comparable in terms of medical and sociodemographic variables, clinical characteristics, HRQoL and disease-specific symptoms or problems. At all the follow-up points, even during the worst period for the patients, the person-centred-care group consistently reported higher scores than the control group. The differences were numerically but not always statistically significant. When using repeated measures in covariance pattern models, statistically significant results were found for HNC-specific problems, swallowing (p= 0.014), social eating (p=0.048) and feeling ill (p=0.021).


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date April 2014
Est. primary completion date April 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

- Eligible for this study were patients diagnosed with HNC, older than 18 years and able to read and write Swedish and, in addition, suitable for outpatient treatment with chemo- and/or radiotherapy, either as primary treatment or in a postoperative setting.

Exclusion Criteria:

- Patients were excluded if they had a previous or concomitant malignancy or were diagnosed and treated for depression as stated in their medical record.

- In order to minimize the risk of bias, none of the patients were to be included if they were taking part in other research studies

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Intervention

Other:
gPCC (Gothenburg Person Centred Care)


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Göteborg University

Outcome

Type Measure Description Time frame Safety issue
Primary Health related quality of life EORTC QLQ-30 EORTC QLQ-35 Baseline No
Primary Health related quality of life EORTC QLQ-30 EORTC QLQ-35 Four weeks No
Primary Health related quality of life EORTC QLQ-30 EORTC QLQ-35 10 weeks No
Primary Health related quality of life EORTC QLQ-30 EORTC QLQ-35 18 weeks No
Primary Health related quality of life EORTC QLQ-30 EORTC QLQ-35 52 weeks No
See also
  Status Clinical Trial Phase
Completed NCT01587105 - Improving Care for Children With Complex Needs N/A
Completed NCT02741700 - SToRytelling to Improve DiseasE Outcomes in GOut: The STRIDE-GO2 Study N/A
Completed NCT06274203 - High Dose Vitamin D Supplementation in Children With Sickle Cell Disease N/A
Recruiting NCT05008159 - A Community-based Program That Supports Physical Activity, Healthy Eating, Social Participation and System Navigation in Older Adults N/A
Completed NCT04073862 - The Norwegian Stepped-Care TF-CBT Study N/A
Active, not recruiting NCT03910894 - Health-related Quality of Life in Colon Cancer
Recruiting NCT06262334 - Evaluating the Fade to Fitness Program: A Barbershop-based Program for Black Men N/A
Completed NCT04756011 - Health-related Quality of Life and Psychosocial Aspects of Diabetes Technology (Insulin Pumps)
Recruiting NCT03081312 - A Study of Family Caregivers' Needs, Burden of Care and Quality of Life Over the Course of a Cancer Illness
Completed NCT03392454 - A Case Series Comparing T+LRTI to Partial Trapeziectomy for Thumb Osteoarthritis
Not yet recruiting NCT05424094 - HRQoL in Overweight and Obese Children/Adolescents N/A
Completed NCT04720677 - Psychometric Properties of Adapted Turkish Version of ISYQOL Questionnaire in Patients With AIS
Completed NCT05829707 - Long-term Outcomes of Breast Cancer Patients After Wound Infiltration Analgesia Phase 4
Completed NCT01784497 - Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation N/A
Active, not recruiting NCT05851339 - Determinants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRS
Recruiting NCT05824312 - HRQOL in Locally Advanced Thyroid Carcinoma
Recruiting NCT05691036 - Bile Acids Metabolism and Genetic Mutation Profile in the ICP in the Indian Population
Recruiting NCT04653298 - Health-related Quality of Life in Adults After Veno-arterial Extra-Corporeal Membrane Oxygenation Which is a Salvage Therapy Used in Patients With Severe Respiratory or Cardiac Failure Who Have Not Responded to Maximal Conventional Medical Therapy